Drug profile · INN
diphenhydramine hydrochloride
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride (DIPHENHYDRAMINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — diphenhydramine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 20
- Programs
- 34
- Data quality
- 0.89
Quick answer
diphenhydramine hydrochloride (DIPHENHYDRAMINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12331126
OX40-binding polypeptides and uses thereof
granted -
US 12084502
CD33-binding polypeptides and uses thereof
granted -
US 12043667
CLEC12a binding polypeptides and uses thereof
granted -
US 12012459
OX40-binding polypeptides and uses thereof
granted -
US 11965017
Serpin fusion polypeptides and methods of use thereof
granted -
US 11919963
CD123-binding polypeptides and uses thereof
granted -
US 11866507
Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
granted -
US 11827691
Serpin fusion polypeptides and methods of use thereof
granted -
US 11566078
PDL1-binding proteins
granted -
US 11560428
CD33-binding polypeptides and uses thereof
granted -
US 11434297
CD123-binding polypeptides and uses thereof
granted -
US 11046752
Serpin fusion polypeptides and methods of use thereof
granted -
US 10745466
Type III secretion system targeting molecules
granted -
US 10730929
Serpin fusion polypeptides and methods of use thereof
granted -
US 10723785
Serpin fusion polypeptides and methods of use thereof
granted -
US 10400029
Serpin fusion polypeptides and methods of use thereof
granted -
US 10344078
Type III secretion system targeting molecules
granted -
US 10093742
Multispecific GITR-binding fusion proteins and methods of use thereof
granted -
US 9920109
Serpin fusion polypeptides and methods of purification thereof
granted -
US 9914765
WAP domain fusion polypeptides and methods of use thereof
granted
Frequently asked questions
What is diphenhydramine hydrochloride?
diphenhydramine hydrochloride (DIPHENHYDRAMINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for diphenhydramine hydrochloride?
DIPHENHYDRAMINE HYDROCHLORIDE is a marketed brand name for diphenhydramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diphenhydramine hydrochloride?
diphenhydramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.